Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis

The influence of ACPA status and characteristics on the course of RA

(2012) Annemiek Willemze et al.   Nature Reviews Rheumatology

Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis

(2011) H. U. Scherer et al.   ANNALS OF THE RHEUMATIC DISEASES

Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis

(2011) P. Suwannalai et al.   ARTHRITIS AND RHEUMATISM

Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

(2011) S. I. Rudnick et al.   CANCER RESEARCH

Complement activation by (auto-) antibodies

(2011) Nina A. Daha et al.   MOLECULAR IMMUNOLOGY

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

(2010) D. van der Woude et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens

(2010) P. Suwannalai et al.   ANNALS OF THE RHEUMATIC DISEASES

Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid

(2010) Hans U. Scherer et al.   ARTHRITIS AND RHEUMATISM

Long-term impact of delay in assessment of patients with early arthritis

(2010) Michael P. M. van der Linden et al.   ARTHRITIS AND RHEUMATISM

Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis

(2010) A. J. M. Schuerwegh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis?

(2010) A. H. M. van der Helm-van Mil et al.   RHEUMATOLOGY

Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

(2010) D. P. C. de Rooy et al.   RHEUMATOLOGY

Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study

(2010) Jennie Ursum et al.   ARTHRITIS RESEARCH & THERAPY

Does damage cause inflammation? Revisiting the link between joint damage and inflammation

(2009) J S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of a single-nucleotide polymorphism inCD40with the rate of joint destruction in rheumatoid arthritis

(2009) Michael P. M. van der Linden et al.   ARTHRITIS AND RHEUMATISM

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

(2009) L. A. Trouw et al.   ARTHRITIS AND RHEUMATISM

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients

(2009) Omri Snir et al.   ARTHRITIS AND RHEUMATISM

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis

(2008) S M van der Kooij et al.   ANNALS OF THE RHEUMATIC DISEASES

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

(2008) Andreea Ioan-Facsinay et al.   ARTHRITIS AND RHEUMATISM

Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated proteins complexed with fibrinogen

(2008) Cyril Clavel et al.   ARTHRITIS AND RHEUMATISM

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE